Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial

Overview of attention for article published in American Journal of Clinical Dermatology, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

facebook: 1 Facebook page
wikipedia: 3 Wikipedia pages

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 3 citations on 3 Wikipedia pages.

Indonesian

Abrositinib

Cited by user Muhammad Anas Sidik on 07 Sep 2025

Abrositinib adalah obat yang digunakan untuk pengobatan dermatitis atopik (eksim). Obat ini merupakan penghambat Janus kinase dan dikembangkan oleh Pfizer.

Hungarian

Abrocitinib

Cited by user Tóth Zsanett Janka on 30 Jun 2023

Abrocitinib, melyet a Cibinqo márkanév alatt értékesítenek, főleg atópiás dermatitis (ekcéma) kezelésére használt gyógyszer.

English

Abrocitinib

Cited by user Zoy1317 on 16 Jun 2023

Abrocitinib, sold under the brand name Cibinqo, is a medication used for the treatment of atopic dermatitis (eczema).

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.